Nordicus Partners Corp Files 8-K

Ticker: NORD · Form: 8-K · Filed: Apr 1, 2025 · CIK: 1011060

Sentiment: neutral

Topics: 8-K, corporate-filing, financial-reporting

TL;DR

Nordicus Partners Corp filed an 8-K on April 1, 2025, for regulatory and financial updates.

AI Summary

Nordicus Partners Corp. filed an 8-K on April 1, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as EKIMAS Corp, AdvanSource Biomaterials Corp, and CARDIOTECH INTERNATIONAL INC, is incorporated in Delaware and has a fiscal year end of March 31. Its principal business is Management Consulting Services.

Why It Matters

This filing provides an update on Nordicus Partners Corp's regulatory and financial reporting status, which is important for investors to stay informed about the company's compliance and financial disclosures.

Risk Assessment

Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain any significant new risks or material adverse information.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

This 8-K filing serves as a Current Report for Nordicus Partners Corporation, primarily for Regulation FD Disclosure and to report Financial Statements and Exhibits.

When was this 8-K filed?

This 8-K was filed on April 1, 2025.

What are the former names of Nordicus Partners Corp?

Nordicus Partners Corp was formerly known as EKIMAS Corp, AdvanSource Biomaterials Corp, and CARDIOTECH INTERNATIONAL INC.

In which state is Nordicus Partners Corp incorporated?

Nordicus Partners Corp is incorporated in Delaware.

What is the business address of Nordicus Partners Corp?

The business address of Nordicus Partners Corp is 280 SOUTH BEVERLY DR., SUITE 505, BEVERLY HILLS, CA 90212.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 1, 2025 regarding Nordicus Partners Corp (NORD).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing